Skip to main content

Advertisement

Table 3 Comparison of outcomes between the two groups in the matched cohort

From: Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study

 Matched
Control (n = 9933)Tranexamic acid (n = 9933)Risk difference (95% CI)p value
Primary outcome
 In-hospital mortality1141 (11.5%)890 (9.0%)− 2.5 (− 3.5 to − 1.6) %< 0.001
Secondary outcomes
 Length of hospital stay, days18 ± 2416 ± 18− 2.4 (− 3.1 to − 1.8)< 0.001
 Discharged to home8124 (81.8%)8410 (84.7%)2.9 (1.7 to 4.1%)< 0.001
 Total health care cost for the admission, USD7573 ± 10,0856757 ± 9127− 816 (− 1109 to − 523)< 0.001
 Thromboembolism212 (2.1%)232 (2.3%)0.2 (− 0.2 to 0.6%)0.34
 Seizure9 (0.0%)5 (0.0%)  
  1. Categorical variables are expressed as the number (%), and continuous variables are presented as the mean ± standard deviation. Risk difference and 95% confidence interval were obtained by generalised estimating equation models with identity link functions
  2. USD United States dollars